{"pub_date": "2016-10-21T17:03:25+0000", "subsection_name": null, "lead_paragraph": "Companies can drop prices and still make money, says the chief executive of GlaxoSmithKline.", "print_page": null, "document_type": "article", "byline": {"person": [{"rank": 1, "organization": "", "lastname": "BAJAJ", "firstname": "Vikas", "role": "reported"}], "original": "By VIKAS BAJAJ"}, "multimedia": [{"width": 190, "height": 126, "url": "images/2016/10/21/opinion/21bajajWEB/21bajajWEB-thumbWide.jpg", "subtype": "wide", "legacy": {"wide": "images/2016/10/21/opinion/21bajajWEB/21bajajWEB-thumbWide.jpg", "widewidth": "190", "wideheight": "126"}, "type": "image"}, {"width": 600, "height": 400, "url": "images/2016/10/21/opinion/21bajajWEB/21bajajWEB-articleLarge.jpg", "subtype": "xlarge", "legacy": {"xlargewidth": "600", "xlargeheight": "400", "xlarge": "images/2016/10/21/opinion/21bajajWEB/21bajajWEB-articleLarge.jpg"}, "type": "image"}, {"width": 75, "height": 75, "url": "images/2016/10/21/opinion/21bajajWEB/21bajajWEB-thumbStandard.jpg", "subtype": "thumbnail", "legacy": {"thumbnail": "images/2016/10/21/opinion/21bajajWEB/21bajajWEB-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "type": "image"}], "section_name": "Opinion", "headline": {"content_kicker": "Taking Note", "main": "The Pharma C.E.O. Who Wants to Lower Drug Prices", "kicker": "Taking Note"}, "source": "The New York Times", "blog": [], "word_count": "700", "web_url": "http://www.nytimes.com/2016/10/21/opinion/the-pharma-ceo-who-wants-to-lower-drug-prices.html", "slideshow_credits": null, "news_desk": "Editorial", "type_of_material": "Editorial", "snippet": "Companies can drop prices and still make money, says the chief executive of GlaxoSmithKline....", "_id": "580a4a6495d0e022439c4868", "abstract": null, "keywords": [{"rank": "1", "name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "N"}, {"rank": "2", "name": "subject", "value": "Health Insurance and Managed Care", "is_major": "N"}]}